Structure Therapeutics Inc.
GPCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001888886
No open-market purchases or sales by Structure Therapeutics Inc. insiders were filed in the last 90 days; 191 institutions reported holding it in 13F filings for Q2 2026, worth $3.62B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Structure Therapeutics Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 122
- +38 vs. Q3 2023
- Shares held
- 42.7M
- +9.88M (+30.1%) vs. Q3 2023
- Total value
- $1.74B
- +$96.7M (+5.9%) vs. Q3 2023
- New holders
- 55
- 37 more added
- Sold out
- 17
- 24 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GPCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 191 | $3.62B |
| Q1 2026 | 198 | $3.23B |
| Q4 2025 | 199 | $4.58B |
| Q3 2025 | 158 | $1.59B |
| Q2 2025 | 173 | $1.14B |
| Q1 2025 | 151 | $990.0M |
| Q4 2024 | 165 | $1.65B |
| Q3 2024 | 161 | $2.69B |
| Q2 2024 | 167 | $2.33B |
| Q1 2024 | 119 | $1.86B |
| Q4 2023 | 122 | $1.74B |
| Q3 2023 | 84 | $1.64B |
| Q2 2023 | 48 | $699.4M |
| Q1 2023 | 38 | $346.2M |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Structure Therapeutics Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Franklin Resources Inc | 542,323 | $22.1M | 0.01% | +291,503+116.2% | Added |
| Capital World Investors | 634,160 | $25.8M | 0.00% | +533,760+531.6% | Added |
| BVF Inc | 812,988 | $33.1M | 0.83% | −937,012−53.5% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 822,813 | $33.5M | 0.62% | +195,000+31.1% | Added |
| Capital International Investors | 850,024 | $34.6M | 0.01% | +850,024 | New |
| Capital Research Global Investors | 973,535 | $39.7M | 0.01% | +628,687+182.3% | Added |
| BlackRock Inc. | 1,061,058 | $43.2M | 0.00% | +533,728+101.2% | Added |
| Logos Global Management LP | 1,070,058 | $43.6M | 4.85% | +570,058+114.0% | Added |
| Avidity Partners Management LP | 1,080,000 | $44.0M | 1.68% | +580,000+116.0% | Added |
| SC China Holding Ltd | 1,065,226 | $44.1M | 5.07% | 00.0% | Unchanged |
| Casdin Capital, LLC | 1,091,867 | $44.5M | 4.39% | −166,299−13.2% | Reduced |
| Citadel Advisors LLC | 1,152,985 | $47.0M | 0.05% | +72,393+6.7% | Added |
| T. Rowe Price Investment Management, Inc. | 1,312,195 | $53.5M | 0.03% | −259,482−16.5% | Reduced |
| Janus Henderson Group PLC | 1,544,416 | $62.8M | 0.04% | −546,907−26.2% | Reduced |
| Price T Rowe Associates Inc | 1,679,436 | $68.5M | 0.01% | −834,127−33.2% | Reduced |
| Adage Capital Partners GP, L.L.C. | 1,756,918 | $71.6M | 0.15% | −43,005−2.4% | Reduced |
| TCG Crossover Management, LLC | 2,109,584 | $86.0M | 9.54% | +606,837+40.4% | Added |
| Federated Hermes, Inc. | 2,267,206 | $92.4M | 0.23% | +1,157,006+104.2% | Added |
| Avoro Capital Advisors LLC | 2,333,333 | $95.1M | 1.31% | +1,333,333+133.3% | Added |
| Driehaus Capital Management LLC | 2,599,079 | $105.9M | 1.28% | +210,203+8.8% | Added |
| FMR LLC | 4,034,584 | $164.4M | 0.01% | +2,444,249+153.7% | Added |
| Wellington Management Group LLP | 4,372,326 | $178.2M | 0.03% | +3,504,747+404.0% | Added |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −1,056,373−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −747,100−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −420,479−100.0% | Sold out |
| First Light Asset Management, LLC | 0 | $0 | 0.00% | −374,412−100.0% | Sold out |
| Holocene Advisors, LP | 0 | $0 | 0.00% | −281,291−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −155,000−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −43,978−100.0% | Sold out |
| SVB Financial Group | 0 | $0 | 0.00% | −35,353−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −42,000−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −27,981−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −22,500−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −13,430−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −12,218−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −5,500−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Washington University | 0 | $0 | 0.00% | −4,274−100.0% | Sold out |
| Toth Financial Advisory Corp | 0 | $0 | 0.00% | −50−100.0% | Sold out |